Pharmafile Logo
Pharmafocus logo
Advanced Search

Sales and Marketing

Showing 15 posts of 11526 posts found.

1740294_bertil-lindmark-webbnyhet

Galecto hires new Chief Medical Officer

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Galecto

Galecto has announced Bertil Lindmark as their new Chief Medical Officer. He began his posting on 1 February 2020.Lindmark joins …
Appointment
rob_van_maanen

New Chief Medical Officer joins Khondrion

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Khondrion has revealed that Dr Rob van Maanen has joined the company as its new Chief Medical Officer (CMO). Dr …
Appointment
top_10_image_2_1

Top Ten most popular articles on Pharmafile.com this week

February 7, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing MERS, Sars, china coronavirus, coronavirus, coronavirus China, wuhan coronaviurs

The Wuhan coronavirus continues to dominate the news, with China admitting its handling of the crisis had shortcomings while Gilead …
News
shutterstock_274590824

Biogen stock surges following patent victory over Mylan for Tecfidera

February 6, 2020 Sales and Marketing Biogen, Mylan, multiple sclerosis, pharma, tecfidera

Biogen has emerged victorious in a patent dispute with Mylan relating to the latter’s multiple sclerosis therapy Tecfidera – a …
News

How AI is making clinical trials more accurate and affordable

February 5, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, AI Clinical Trials, Apple, Apple Watch., apple watch, clinical trials

Clinical trials are one of the longest and most expensive steps of bringing a drug to market. Conor Kavanagh investigates …
Feature
holly_springs_9frontflags

Seqirus’ Audenz becomes first FDA-approved cell-based adjuvant influenza A vaccine

February 5, 2020 Research and Development, Sales and Marketing FDA, influenza, pharma, seqirus

The FDA has just approved the first adjuvanted, cell-based vaccine for the prevention of influenza A (H5N1) in the US, …
News

Europe’s CHMP recommends Pfizer’s biosimilar of Roche’s MabThera

February 4, 2020 Manufacturing and Production, Sales and Marketing MabThera, Pfizer, Ruxience, biosimilar, pharma

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has revealed that it has awarded a positive opinion for …
News

Insider Interview: Reducing the risk of adverse cardiovascular events

February 3, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Insider Interview, cardiovascular, heart disease, pharma

Rodrigo Gribble, Vice President Cardiovascular at AstraZeneca, breaks down recently published data from the PEGASUS trial of ticagrelor, a potential …
Feature
gilead-sciences

Gilead’s experimental Ebola drug being tested in patients infected with coronavirus

February 3, 2020 Sales and Marketing Coronavirus Wuhan, MERS, Sars, Wuhan, coronavirus, coronavirus China

China and the US are testing Gilead’s remdesivir in patients with the coronavirus, in the hopes of developing an effective …
News
humacao_exterior

BMS pulls Opdivo+Yervoy combo in EU for advanced non-small cell lung cancer

February 3, 2020 Sales and Marketing BMS, Cancer, Europe, Yervoy, lung cancer, opdivo

Bristol-Myers Squibb has confirmed it has withdrawn its application with the European Commission for its combination of Opdivo (nivolumab) and …
News
mercado_de_mariscos_de_wuhan_cerrado_tras_detectarse_ahi_por_primera_vez_el_nuevo_coronavirus_

More Britons evacuated from Wuhan as UK donates £20 million to speed up vaccine

February 3, 2020 Sales and Marketing China virus, MERS, Sars, Wuhan Coronavirus, coronavirus, coronavirus China

More Britons have been flown back from Wuhan, the heart of the coronavirus outbreak, while the UK government has donated …
News
abbvie_0

AbbVie’s Venclyxto pins down CHMP approval for treatment-naive chronic lymphocytic leukaemia

February 3, 2020 Sales and Marketing AbbVie, CHMP, EMA, Venclyxto, pharma

The European Medicines Agency (EMA)’s Committee for Medicinal Products for Human Use (CHMP) has awarded recommendation to AbbVie’s Venclyxto (venetoclax), …
News
15031804271_3791dafae1_b

FDA approves first treatment for peanut allergy

February 3, 2020 Sales and Marketing FDA, FDA Peanuts, peanut, peanut allergy, peanut medicine

The FDA has approved its first treatment for peanut allergy in patients between ages four and 17. The drug is …
News
david_hallett

AI firm Exscientia appoints COO and Head of Drug Discovery

January 31, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Exscientia, appointment

AI drug discovery firm Exscientia has announced the appointment of Dr David Hallett as its Chief Operating Officer and Head …
Appointment
pharmafocus_janfeb_2020_cover

Read the January/February 2020 edition of Pharmafocus online now!

January 30, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, UK, US, brexit, coronavirus, opioid crisis, pharma

Pharmafocus returns for the New Year with its January/February issue, and things have certainly changed since we left. Brexit got …
News
The Gateway to Local Adoption Series

Latest content

Sandoz launches allergy relief nasal spray in Germany and Switzerland

April 9, 2026

Japan approve Daiichi Sankyo’s Enhertu as a second-line treatment for gastric cancer

April 9, 2026

Trelleborg to take part in Medtec Japan 2026

April 8, 2026

Kainova Therapeutics expands phase I/II trial of antibody drug

April 7, 2026

Eisai starts enrolment for phase 2 narcolepsy study evaluating E2086

April 7, 2026